Aeron is a physicist passionate about quantum mechanics, nano-scale systems, optics, and biology. He received his bachelor’s degree in Electrical Engineering and Computer Science from Berkeley, his PhD in Physics from UCSD, and was a postdoctoral fellow at LBNL.

He has over 20 peer-reviewed publications in topics ranging from superfluidity, polymers, and surface chemistry to plasmonics and photonics. Aeron’s passion for biology has always been strong, but exposure to the biophysics at UCSD cemented his love for the topic. Aeron went on to become a Research Staff Member at HGST developing nano scale optical characterization techniques.

In his current role at EpiBiome he lends his expertise in programming and data analysis by overseeing the informatics that next-generation sequencing requires. His expertise in spectroscopy and microscopy is directly applicable to developing optical and electron microscopy protocols for screening and characterizing previously unknown bacteriophages.

Talk Title: Building scalable data science infrastructure to fight the growing threat of antibiotics resistance.

About EpiBiome:
EpiBiome is a venture backed biotech startup based in the Bay Area that is using sequencing and automation to fight the growing threat of antibiotics resistant bacteria. Our mission requires massive integration of information from a broad variety of sources in order to make intelligent desicisions in designing next generation therapeutic approaches to bacterial infections. Our initial efforts are focused on understanding the correlation between microbial populations and probiotic versus disbiotic states in agriculture and human health, as well as the development of bacteriophage based cocktails in order to change the balance of microbial communities in a beneficial fashion. The global scale of the problem of antibiotic resistance requires an integration of data arising from large scale epidemiological studies with in-house lab automated discovery of basic molecular biology and microbiology. As graduates from the Illumina Accelerator Program, our biology work has been driven by massive sequencing efforts to understand the fundamental genetics of the bacteria and bacteriophage we are seeking to understand in order to bring new bioremediation products to the market at the rapid pace required to stay ahead of resistance.